DarioHealth appoints new CFO as Ben-David retires

NEW YORK - DarioHealth Corp. (NASDAQ: DRIO), a prominent digital health company with a current market capitalization of $10.6 million, disclosed today that its Chief Financial Officer, Zvi Ben-David, is set to retire on May 15, 2025. According to InvestingPro data, the company’s stock has shown a modest gain of 0.77% year-to-date, trading at $1.31. Chen Franco-Yehuda will take over the CFO responsibilities, as well as the roles of Treasurer and Secretary, upon Ben-David’s retirement. The announcement comes as part of a planned transition, with Ben-David continuing to serve the company in an advisory capacity after his departure until the end of June.

Ben-David expressed confidence in Franco-Yehuda’s capabilities, stating, "I am confident in Chen’s ability to lead the Company’s financial strategy and contribute to its continued growth." His tenure at DarioHealth saw the transformation of the company into a multi-condition digital health platform, expanding its offerings to include diabetes, hypertension, mental health, weight management, and musculoskeletal care. The company maintains a healthy liquidity position with a current ratio of 2.25, though InvestingPro analysis indicates the company is currently burning through cash at a considerable rate.

Franco-Yehuda brings a wealth of experience to her new role, having recently served as CFO, Treasurer, and Secretary at Pluri Inc., a global biotech firm. Her background includes significant achievements in financial strategy, capital markets, and strategic growth initiatives. Notably, she was recognized with the Israeli CFO Excellence Award in January 2025.

Erez Raphael, CEO of DarioHealth, thanked Ben-David for his service and highlighted his contributions to the company’s strategic growth. Raphael also expressed enthusiasm for Franco-Yehuda’s appointment, anticipating the benefits her expertise will bring to the company’s future endeavors.

DarioHealth is known for revolutionizing digital health management for chronic conditions through its user-centric platform, providing personalized interventions and data-driven analytics. The company caters to a global market, including health plans, payers, self-insured employers, care providers, and consumers.

This news follows DarioHealth’s commitment to transparency and regulatory compliance, as detailed in their cautionary note regarding forward-looking statements. The company maintains that actual results could differ materially from any forward-looking statements due to a variety of factors, including market conditions and regulatory approvals.

The information reported is based on a press release statement from DarioHealth Corp. InvestingPro analysis reveals additional insights about the company’s financial health, with 12 more exclusive ProTips available to subscribers. While the company’s overall Financial Health Score currently stands at ’Weak’, detailed analysis suggests the stock may be slightly undervalued at current levels.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.